CLDN5 and chronic kidney disease: While previous studies have shown suPAR-induced podocyte structural changes in CKD models,28,30 our PEMP analysis revealed no significant differences in podocyte morphology following acute suPAR exposure, with filtration slit density and Claudin 5/Podocin ratios remaining unchanged.